Large pharmaceutical companies are willing to buy smaller biotech firms for ever-steeper premiums.
But S&P said N.J.’s severely underfunded pensions is still why it rates it lower than any other state but Illinois.
Its bankruptcy has accelerated an exodus that’s adding to the island’s economic misery.
Please log back in before proceeding.
There was an error logging in. Please try again.
Congrats! You are now logged in. Your exam is being submitted.
